2.9 vs. 3.1, p<.001) and median follow-up (15.9 months vs. 6 vs. 14.6, p=.002) differed between OC vs. SAC vs. MAC RPN patients respectively. The percentage reduction in eGFR at 13.9 months was significantly reduced in patients undergoing OC vs. MAC (2.5% vs. -9.9%, p=.001) adjusting for R.E.N.A.L. score, American Society of Anesthesiologists (ASA) score, body mass index (BMI) and baseline eGFR (Figure 1) . In a multivariable cox proportional hazards model, the risk of CKD upstaging was no different in patients undergoing OC vs SAC or MAC (HR= 0.51, p=.260). Greater EBL (178.0 vs. 117.1, p=.008) was seen in patients undergoing OC vs. MAC RPN.
No differences in NNPV removed (p=.586), PSM (p=.849), or complications (p=.693) were found between the approaches.
Conclusions:
This study suggests that there may be a renal function advantage to OC RPN.
No difference in NNPV removed between groups suggests that the lack of ischemic damage underlies the renal function benefit of OC RPN. Improved renal function without increased risk of PSM or complications suggests that when technically feasible, off-clamp RPN is a consideration in patients with low and intermediate complexity tumors. 
